# 2026-15846: FDA's Advisory Committee Paperwork Hits OMB Desk

2026-15846, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration Advisory Committees, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-08-05, effective Submit written comments (including recommendations) on the collection of information by September 4, 2026. (as of 2026-08-12).

- Canonical: https://policyrisk.com/federal-register/2026-15846
- As of: 2026-08-12
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-15846
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration Advisory Committees
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 50555
- Published: 2026-08-05
- Effective: Submit written comments (including recommendations) on the collection of information by September 4, 2026.
- Comments close: 2026-09-04
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-08-12

## In one line

FDA's Advisory Committee Paperwork Hits OMB Desk

## Summary

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27
- [2026-20727](https://policyrisk.com/federal-register/2026-20727): Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorgani…, 2026-10-09

## Sources
- [2026-15846 on federalregister.gov](https://www.federalregister.gov/documents/2026/08/05/2026-15846/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-15846 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-08-05/pdf/2026-15846.pdf)

## Related
- [Previous: 2026-15843, Proposed Information Collection Activity; Unaccompanied Refugee Minors Program…](https://policyrisk.com/federal-register/2026-15843)
- [Next: 2026-15847, Rail Passenger Liability Cap Adjustment as Required by Section 11415 of the Fix…](https://policyrisk.com/federal-register/2026-15847)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-15846 (as of 2026-08-12).